Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma

The peripheral blood absolute lymphocyte/monocyte count ratio at diagnosis (ALC/AMC-DX) predicts survival in classical Hodgkin lymphoma (cHL). However, a limitation of the ALC/AMC-DX is the inability to assess sequentially the host/tumor interaction during treatment. Therefore, we retrospectively ex...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood cancer journal (New York) 2013-04, Vol.3 (4), p.e110-e110
Hauptverfasser:	Porrata, L F, Ristow, K M, Habermann, T M, Macon, W R, Witzig, T E, Colgan, J P, Inwards, D J, Ansell, S M, Micallef, I N, Johnston, P B, Nowakowski, G, Thompson, C A, Markovic, S N
Format:	Artikel
Sprache:	eng
Schlagworte:	692/699/67/1059/99 692/699/67/1857 692/699/67/1990/291/1556 Biomedical and Life Sciences Biomedicine Cancer Research Clinical outcomes Hematology Oncology Original original-article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!